Get the Stockscreener App
4.71
1.07%
0.05
After Hours:
4.71
Sight Sciences Inc stock is traded at $4.71, with a volume of 512.44K.
It is up +1.07% in the last 24 hours and down -18.93% over the past month.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
See More
Previous Close:
$4.66
Open:
$4.68
24h Volume:
512.44K
Relative Volume:
2.90
Market Cap:
$239.46M
Revenue:
$81.06M
Net Income/Loss:
$-55.55M
P/E Ratio:
-3.226
EPS:
-1.46
Net Cash Flow:
$-47.98M
1W Performance:
-10.63%
1M Performance:
-18.93%
6M Performance:
-20.97%
1Y Performance:
+158.79%
1-Day Range:
$4.56
$4.90
1-Week Range:
$4.46
$5.48
52-Week Range:
$1.575
$8.45
Sight Sciences Inc Stock (SGHT) Company Profile
Name
Sight Sciences Inc
Sector
Industry
Phone
(415) 889-0550
Address
4040 CAMPBELL AVE,, MENLO PARK
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-21-24 | Initiated | Lake Street | Buy |
| Sep-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-12-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-12-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-10-23 | Downgrade | Citigroup | Buy → Neutral |
| Jan-06-23 | Upgrade | Stifel | Hold → Buy |
| Oct-04-22 | Initiated | Needham | Hold |
| Jul-26-22 | Initiated | Stifel | Hold |
| Feb-03-22 | Initiated | William Blair | Outperform |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
View All
Sight Sciences Inc Stock (SGHT) Latest News
Lake Street cuts Sight Sciences stock rating to hold amid market challenges - Investing.com Australia
Lake Street Capital Markets Downgrades Sight Sciences Inc. (SGHT) to Hold - StreetInsider.com
Sight Sciences (NASDAQ:SGHT) Downgraded to Hold Rating by Lake Street Capital - MarketBeat
Rezolute, Inc. (NASDAQ:RZLT) Receives $11.57 Consensus Target Price from Analysts - Defense World
Global Dry Eye Disease Treatment Market Projected to Cross USD 9 Billion by 2030 | DelveInsight - The Malaysian Reserve
Sight Sciences (SGHT) Scheduled to Post Earnings on Thursday - MarketBeat
Microsoft Co. (NASDAQ:MSFT) Shares Acquired by Parametrica Management Ltd - Defense World
KCK LTD.'s Strategic Reduction in NeuroPace Inc Shares - Yahoo Finance
KCK LTD. Adjusts Stake in NeuroPace Inc - GuruFocus.com
Preview: Zynex's Earnings - Benzinga
Sight Sciences, Inc. (NASDAQ:SGHT) Insider Sells $122,471.91 in Stock - MarketBeat
Sight Sciences CCO Matthew Link sells $244,900 in stock By Investing.com - Investing.com South Africa
Sight Sciences CCO Matthew Link sells $244,900 in stock - Investing.com
The Manufacturers Life Insurance Company Increases Stock Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World
The Manufacturers Life Insurance Company Buys New Position in Applied Optoelectronics, Inc. (NASDAQ:AAOI) - Defense World
The Manufacturers Life Insurance Company Invests $90,000 in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World
The Manufacturers Life Insurance Company Purchases Shares of 13,551 LifeMD, Inc. (NASDAQ:LFMD) - Defense World
The Manufacturers Life Insurance Company Invests $123,000 in Lincoln Educational Services Co. (NASDAQ:LINC) - Defense World
The Manufacturers Life Insurance Company Invests $102,000 in Backblaze, Inc. (NASDAQ:BLZE) - Defense World
Sight Sciences' IPO Lock-up Period Ends On Jan 11 - RTTNews
This Insider Has Just Sold Shares In Sight Sciences - Simply Wall St
Sight Sciences, Inc. (NASDAQ:SGHT) Insider Matthew Link Sells 20,734 Shares - MarketBeat
Sight sciences' chief commercial officer sells shares worth $244,878 - Investing.com
Sight sciences' chief commercial officer sells shares worth $244,878 By Investing.com - Investing.com UK
KCK LTD. Reduces Stake in NeuroPace Inc - GuruFocus.com
Sight Sciences to Report Third Quarter Financial Results on November 7, 2024 - The Manila Times
GenSight Biologics Announces LUMEVOQ® Scientific Updates at AAO 2024 - Yahoo Finance
Dry Eye Disease Treatment Devices Market Size and Growth Analysis - News in Assen
(SGHT) Trading Report - Stock Traders Daily
Single TearCare® Treatment Improved Functional Visual - GlobeNewswire
Single TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial - StockTitan
Renaissance Technologies LLC Sells 105,556 Shares of Sight Sciences, Inc. (NASDAQ:SGHT) - MarketBeat
Lineage Looking to Restore Sight, Hearing, Movement - San Diego Business Journal
Powered Surgical Instruments Market Growth Report, Analysis And Overview To 2033 - WhaTech
Have Sight Sciences Insiders Been Selling Stock? - Simply Wall St
(SGHT) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Sight Sciences shares reiterate Buy rating from Lake Street on growth potential - Investing.com
Sight Sciences CTO sells shares worth over $18k By Investing.com - Investing.com South Africa
Sight Sciences COO sells shares worth over $20,000 - Investing.com India
Sight Sciences COO sells shares worth over $20,000 By Investing.com - Investing.com South Africa
Reviewing WK Kellogg (NYSE:KLG) & Forafric Global (NASDAQ:AFRI) - Defense World
Aurubis (ETR:NDA) Stock Price Down 1% – Here’s Why - Defense World
Insider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) CTO Sells 3,167 Shares of Stock - MarketBeat
Sight Sciences CEO Paul Badawi sells shares worth over $76k By Investing.com - Investing.com South Africa
Sight Sciences executive sells shares worth over $29,000 - Investing.com India
Sight Sciences executive sells shares worth over $29,000 By Investing.com - Investing.com Australia
Sight Sciences CEO Paul Badawi sells shares worth over $76k - Investing.com Australia
Sight Sciences CTO sells shares worth over $18k - Investing.com
Sight Sciences Inc Stock (SGHT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.47%
1.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):